Report DMCA Propensity score matching/reweighting analysis comparing intravenous golimumab to infliximab for ankylosing spondylitis
* Please fill this form as much details as possible, we will respond to your request within 2 to 3 business days.
* Please fill this form as much details as possible, we will respond to your request within 2 to 3 business days.